Author: Editor

Researchers tracking dementia cases in Welsh adults have uncovered the strongest evidence yet that shingles vaccine reduces the risk of developing the brain disease. A study analyzing health records of over 280,000 older adults found that those who received Zostavax, a now largely discontinued shingles vaccine, were 20% less likely to be diagnosed with dementia over the next seven years compared to those who were not vaccinated. Pascal Geldsetzer of Stanford University stated, “For the first time, we can say with more confidence that the shingles vaccine causes a reduction in dementia risk. If this is indeed a causal effect,…

Read More